as on December 17, 2025 at 10:37 pm IST
Day's High
5.53%
Upside
52 Week's Low
52 Week's High
15.58%
Downside
48.49%
Upside
Check Molecular Partners Ag -adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$152.8M
EPS (TTM)
-1.4857
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-56.7M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-51.42%
Compare market cap, revenue, PE, and other key metrics of Molecular Partners Ag -adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $152.8M | NA | NA | 0.00% | ||
| BUY | $42.8B | 428.77% | -16.34 | -264.83% | |
| BUY | $51.7B | 182.13% | 1262.9 | 1.36% | |
| BUY | $116.8B | 92.03% | 32.05 | 31.35% | |
| BUY | $79.8B | 50.41% | 18.05 | 32.13% |
The Molecular Partners Ag -adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Molecular Partners Ag -adr investment value today
Current value as on today
₹82,215
Returns
Returns from Molecular Partners Ag -adr Stock
Dollar Returns*
₹6,406 (+6.41%)
Based on 11 analysts
9.09%
Buy
27.27%
Hold
63.64%
Sell
Based on 11 analysts, 63.64% of analysts recommend a 'SELL' rating for Molecular Partners Ag -adr. Average target price of $10.74
Get share price movements and forecasts by analysts on Molecular Partners Ag -adr.
What analysts predicted
62.94%UPSIDE
Target Price
$10.74
Current Price
$3.98
Analyzed by
11 Analysts
Target
$10.74
Molecular Partners Ag -adr target price $10.74, a slight upside of 62.94% compared to current price of $3.98. According to 11 analysts rating.
Search interest for Molecular Partners Ag -adr Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 November
Wed, 04:22 PM
-Molecular Partners presents new data on MP0712, highlighting first human images and supporting mechanism of action for small cell lung cancer treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, MOLN stock has moved up by 14.8%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -20.39M → -11.83M (in $), with an average increase of 72.3% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 950.6% return, outperforming this stock by 987.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 171.7% return, outperforming this stock by 192.1%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 2.73M → 681.0K (in $), with an average decrease of 49.7% per quarter
| Organisation | Molecular Partners Ag -adr |
| Headquarters | Wagistrasse 14, Schlieren, Switzerland, 8952 |
| Industry | Services |
| CEO | Dr. Patrick Amstutz Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Michael Tobias Stumpp Ph.D. | Co-Founder, Executive VP of Projects & Member of Management Board |
Mr. Robert Hendriks | Senior VP of Finance |
Dr. Philippe Legenne M.B.A., M.D. | Chief Medical Officer & Member of the Management Board |
Mr. Daniel Steiner Ph.D. | Senior Vice President of Research & Technology |
Dr. Patrick Amstutz Ph.D. | Co-Founder, CEO, Member of Management Board & Director |
Ms. Renate Gloggner | Executive VP of People & Community and Member of Management Board |
Mr. Martin Steegmaier Ph.D. | Chief Scientific Officer |
Mr. Seth D. Lewis | Senior Vice President of Investor Relations, Communications & Strategy |
Mr. Michael Pitzner | General Counsel, Compliance Officer, Senior VP Legal & Business Development |
Mr. Alexander Zurcher | COO & Member of Management Board |
Molecular Partners Ag -adr share price today is $3.98 as on . Molecular Partners Ag -adr share today touched a day high of $4.2 and a low of $3.98.
Molecular Partners Ag -adr share touched a 52 week high of $5.91 on and a 52 week low of $3.36 on . Molecular Partners Ag -adr stock price today i.e. is trending at $3.98,which is 32.66% down from its 52 week high and 18.45% up from its 52 week low.
Molecular Partners Ag -adr market capitalisation is $0.00T as on .
Indian investors can start investing in Molecular Partners Ag -adr (MOLN) shares with as little as ₹90.346 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹903.46 in Molecular Partners Ag -adr stock (as per the Rupee-Dollar exchange rate as on ).
Based on Molecular Partners Ag -adr share’s latest price of $3.98 as on December 17, 2025 at 10:37 pm IST, you will get 2.5126 shares of Molecular Partners Ag -adr. Learn more about
fractional shares .